Laparoscopic versus open radical cystectomy for the management of bladder cancer: Mid-term oncological outcome

Objective:  To compare the mid‐term oncological outcome of laparoscopic radical cystectomy (LRC) with those of open radical cystectomy (ORC). Methods:  From June 2003 to February 2008, 36 LRCs were carried out at our institute for the treatment of bladder cancer. Clinical and oncological data were r...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of urology Vol. 17; no. 1; pp. 55 - 61
Main Authors Ha, U-Syn, Kim, Sung In, Kim, Su Jin, Cho, Hyuk-Jin, Hong, Sung-Hoo, Lee, Ji Youl, Kim, Joon Chul, Kim, Sae Woong, Hwang, Tae-Kon
Format Journal Article
LanguageEnglish
Published Melbourne, Australia Blackwell Publishing Asia 01.01.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective:  To compare the mid‐term oncological outcome of laparoscopic radical cystectomy (LRC) with those of open radical cystectomy (ORC). Methods:  From June 2003 to February 2008, 36 LRCs were carried out at our institute for the treatment of bladder cancer. Clinical and oncological data were retrospectively analyzed. A match‐pair comparison with an historical series of 34 patients who were submitted to ORC between 1996 and 2003 was carried out. Results:  Median follow‐up of the LRC group was 21 months (3–56 months). Pathological stage or grade was similar in the two groups. There was no significant difference between the LRC and ORC groups in terms of 3‐year overall (64.2% vs 72.6%, respectively; P = 0.682), cancer‐specific (73.0% vs 75.3%, respectively; P = 0.951), and recurrence‐free survival (70.5% vs 72.5%, respectively; P = 0.715) rates. In a subgroup analysis according to stage, there was also no significant difference in the 3‐year disease‐specific survival after LRC or ORC for organ‐confined (pT1 and pT2; 85.7% vs 83.9%, respectively; P = 0.256) or extravesical disease (pT3 and pT4; 73.3% vs 63.8%, respectively; P = 0.825). Conclusion:  These findings suggest that LRC provides mid‐term oncological outcomes similar to those of ORC in the management of bladder cancer.
Bibliography:istex:7426F5CF500D7B96860D898C92825F7F5EED92A6
ArticleID:IJU2425
ark:/67375/WNG-FM36ZF57-4
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0919-8172
1442-2042
DOI:10.1111/j.1442-2042.2009.02425.x